AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Levocetrizine Dihydrochloride
8 registrations across 4 African markets— 8 active
Markets with Levocetrizine Dihydrochloride
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Glencet Tablet | 🇰🇪Kenya | Glenmark Pharmaceuticals Limited | active | Mar 2031 |
| Glencet Tablet | 🇰🇪Kenya | Glenmark Pharmaceuticals Limited | active | Feb 2031 |
| LAZINE Tablets | 🇷🇼Rwanda | M/s. Hetero Labs Limited | active | Aug 2029 |
| Fitin Syrup (Levocetirizine 2.5mg) Oral Syrup | 🇿🇲Zambia | Medley Pharmaceuticals Limited | active | Dec 2028 |
| levohistam oral drops Oral Drops | 🇹🇿Tanzania | Utopia Pharmaceutical | active | — |
| LEVOZIN Syrup | 🇹🇿Tanzania | Lincoln Pharmaceuticals Limited | active | — |
| Glencet Tablets | 🇹🇿Tanzania | Glenmark Pharmaceuticals Limited | active | — |
| LEVOZAL Tablets | 🇹🇿Tanzania | JAMJOOM PHARMACEUTICALS COMPANY | active | — |
Levocetrizine Dihydrochloride in Africa — Regulatory Overview
Levocetrizine Dihydrochloride is registered across 4 African markets with 8 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tanzania, Kenya, Rwanda, Zambia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 8 registrations, 8 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.